Atlas Arteria Group (ASX: ALX) share price is in focus after the company posted a statutory net loss after tax of $73.3 million for the first half of 2026, mainly due to non-operating costs, while underlying net profit after tax rose to $94.3 million, up 29% on the prior period.
Image source: Getty Images
What did Atlas Arteria report?
- Statutory net loss after tax: $(73.3) million (H1 2025: $73.3 million profit)
- Underlying net profit after tax: $94.3 million (up 29% from H1 2025)
- Proportional toll revenue: $917.5 million (down 3.9%)
- Proportional EBITDA: $702.6 million (down 3.6%)
- Operating free cash flow per security: 19.1 cps (down 1.5%)
- Interim distribution: 20.0 cps; full-year guidance reaffirmed at 40.0 cps
What else do investors need to know?
Atlas Arteria's results were weighed down by one-off costs tied to settling the Chicago Skyway Ontario Teachers' Pension Plan put option and costs related to the unsolicited takeover offer from IFM. Excluding these, the company's operational results proved fairly resilient despite foreign exchange headwinds weighing on revenue and cash flow.
IFM's takeover saw its stake in Atlas Arteria lift from 34.5% to 67.4%. The board says it remains committed to its strategy and is now engaging closely with IFM to deliver value for all securityholders. The company also completed extinguishing the Chicago Skyway put option, funded by new corporate debt.
Atlas Arteria reported progress on legislative reform in Virginia, where changes are set to streamline future rate cases for its Dulles Greenway business. There were also steady operational metrics across its European and North American assets.
What did Atlas Arteria management say?
Hugh Wehby, Chief Executive Officer, said:
Our results for H1 2026 were affected by a number of non-operating costs, as well as unfavourable foreign exchange movements. Excluding these items, the underlying performance of our businesses was stable. The IFM Takeover Offer was significant for Atlas Arteria and our securityholders. As a result of the Takeover Offer, IFM's relevant interest is now around 67%, and the Boards and management remain focused on delivering value for all securityholders.
What's next for Atlas Arteria?
Atlas Arteria reaffirmed its 2026 full-year distribution guidance of 40.0 cps, with the interim distribution set at 20.0 cps for payment in October 2026. The group says it will continue to align distributions with free cash flow, paying out 90–110% of free cash flow on a full-year basis.
Looking ahead, the company is focusing on optimising its global toll road portfolio, unlocking cash flow at the Dulles Greenway, and preparing for French concession retenders. Management will update 2027 distribution guidance with its February 2027 results.
Atlas Arteria share price snapshot
The Atlas Arteria share price has underperformed the S&P/ASX 200 index (ASX: XJO) over the past 12 months with a decline of almost 11%.
